To sustain rapid revenue growth, medical device manufacturers are increasingly turning to significant corporate cost saving programmes, often requiring across-the-board cuts between 15 and 30%.

Companies are under enormous pressure to introduce products to market faster while also meeting the escalating demands of regulators and payors for post-market research, requiring investment in infrastructure and expertise to maximise reimbursement and keep products on the market.

How can manufacturers effectively reconcile these seemingly contradictory challenges?

Read the white paper, Transforming Medical Device Development: Achieving Challenging Mandates for Cost Savings and Pipeline Productivity, to unlock key strategies for maximising value from your strategic partnerships.

Transforming Medical Device Development